EGFR and non-small cell lung carcinoma: PI3K/AKT/ mTOR pathway are typical signal transduction pathways that are crucial for first/second-generation EGFR-TKIs and third-generation EGFR-TKIs such as Osimertinib resistance events in NSCLC, and also defined as downstream of the IGF1R signaling pathways.